Skip to content

Exploring the Timing of Early VV-ECMO Initiation in ARDS: A Multicenter, Prospective Cohort Study

Exploring the Timing of Early VV ECMO Initiation in ARDS: A Multicenter, Prospective Cohort Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500111005
Enrollment
Unknown
Registered
2025-10-23
Start date
2025-11-21
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute respiratory distress syndrome

Interventions

Observation group:None

Sponsors

The First Affiliated Hospital of Guangzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Age>= 18 years, regardless of gender; 2.Patients with ARDS meeting the diagnostic criteria of the "New Global Definition of Acute Respiratory Distress Syndrome" published by ESICM in 2023; 3.Receiving VV-ECMO support and having received invasive mechanical ventilation prior to the initiation of VV-ECMO; 4.The patient or legal representative has voluntarily signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1.Patients who have received a lung transplant or for whom VV-ECMO support was initiated for the purpose of bridge-to-lung transplantation therapy; 2.Patients with other severe diseases and a life expectancy of 15 hours per day): PaO2 55%). b) Patients requiring long-term home non-invasive ventilation support due to stable chronic respiratory failure: patients with severe chronic hypercapnia and a history of hospitalization due to acute respiratory failure, who still present with significant daytime persistent hypercapnia (PaCO2 >= 53 mmHg) 2 to 4 weeks after hospitalization for an acute exacerbation of COPD. 4.Complicated by cardiogenic shock requiring VA-ECMO support; 5.Patients who underwent ECMO cannulation at an outside hospital and for whom mechanical ventilation parameters prior to ECMO are unavailable; 6.Pregnant or lactating women; 7.Any condition that, in the investigator’s opinion, would increase the risk to the patient or interfere with the conduct of the clinical trial.

Design outcomes

Primary

MeasureTime frame
Survival rate at 60 days;

Secondary

MeasureTime frame
ECMO weaning success rate;Duration of mechanical ventilation;ECMO complication rate;ECMO survival at 28 days, 3 months, and 6 months;

Countries

China

Contacts

Public ContactYimin Li

The First Affiliated Hospital of Guangzhou Medical University

dryiminli@vip.163.com+86 180 2738 7998

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026